Isotype distribution and clinical relevance of anti-β2-glycoprotein I (β2-GPI) antibodies: Importance of IgA isotype

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 574-579

  Lakos, Gabriella ^b   Kiss, E ^b   Regeczy N ^b   Tarjan P ^a,b   Soltesz P ^b   Zeher, M ^b   Bodolay, E ^b   Szakony, Sz ^b   Sipka, S ^b   Szegedi, Gy ^b  

^a Hetenyi Geza County Hospital   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Anti 2 glycoprotein I antibodies; Anti phospholipid syndrome; IgA; IgG; IgM

Indexed keywords

BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS; PROTEIN ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE;

EID: 0032783226     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01007.x     Document Type: Article

References (30)

1. 1 Harris EN, Gharavi AE, Hughes GR. Anti-phospholipid antibodies. Clin Rheum Dis 1985; 11:591-609.
2. 2 Hughes GR, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13:486-9.
3. 3 Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335:1544-7.
4. 2-glycoprotein I is bound to a suitable surface. Thromb Haemost 1995; 73:29-34.
5. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179:457-62.
6. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 83-90.
7. 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995; 91:471-3.
8. 2-glycoprotein I as an antigen. J Immunol Methods 1991; 143:223-9.
9. 2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93:181-6.
10. 2-glycoprotein-1 than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
11. 2,-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 1996; 36:1606-7.
12. 12 Gharavi AE, Harris EN, Asherson RA, Hughes GR. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46:1-6.
13. 13 Kalunian KC, Peter JB, Midlekauff HR, Sayre J, Ando DG, Mangotich M, Hahn BH. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988; 85:602-8.
14. 14 Lopez LR, Santos ME, Espinoza LR, La-Rosa FG. Clinical significance of immunoglobulin A versus immunoglobulins G and M anticardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion. Am J Clin Pathol 1992; 98:449-54.
15. 15 Loizou S, Cifiner C, Weetman AP, Walport MJ. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Imunol 1992; 90:434-9.
16. 16 Escalante A, Brey RL, Mitchell BD Jr, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995; 98:559-65.
17. 17 Burden AD, Gibson IW, Rodger RS, Tillman DM. IgA anticardiolipin antibodies associated with Henoch-Schönlcin purpura. J Am Acad Dermatol 1994; 31:857-60.
18. 18 Wilson WA, Morgan-Ost C, Barton EN, Smikle M, Hanchard B, Blattner WA, Doggett S, Gharavi AE. IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis. Lupus 1995; 4: 138-41.
19. 2-glycoprotein I, antiprothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997; 24:1710-5.
20. 2-glycoprotein I and anti-prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies, Thromh Haemost 1997; 78:1008-14.
21. 21 Hughes GR. Connective tissue diseases and skin. Clin Exp Dermatol 1984; 9:535-44.
22. 22 Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GR. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37:568-71.
23. 23 Khamashta MA, Cervera R, Asherson RA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335:1541-4.
24. 2-glycoprotein I: preparation, properties, and availability to investigators. Clin Chem 1996; 42:1116-7.
25. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:1466-74.
26. 26 Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelism with heparin-induced thrombocytopenia. Thromb Haemost 1996, 75:536-41.
27. 2:-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7:441-55.
28. 2-glytcoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol 1998; 25:675-80.
29. 2-glycoprotein I in patients with syslcmic lupus erythematosus. J Rheumatol 1998; 25:74-78.
30. 30 Falcon CR, Martinuzzo ME, Forastiero RR, Cerrato GS, Carreras LO. Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 1997; 89:975-80.